A Review of EMEQ: Navigating Concentrated Emerging Market Equities
Finance

A Review of EMEQ: Navigating Concentrated Emerging Market Equities

authorBy Mariana Mazzucato
DateJul 13, 2026
Read time2 min

The Nomura Focused Emerging Markets Equity ETF (EMEQ) offers investors a targeted approach to engaging with leading companies in developing economies. This ETF specifically concentrates its holdings in key growth sectors, such as semiconductors and artificial intelligence infrastructure, aiming to capture the upside potential of these innovative industries within emerging markets. This strategy diverges from traditional broad-based emerging market investments that often rely on overarching macroeconomic trends.

While EMEQ has demonstrated remarkable performance, achieving an 81.80% NAV return since September 2024, its concentrated nature warrants careful consideration. With a significant portion of its assets, nearly 68%, allocated to its top ten holdings, the fund inherently carries both amplified potential for gains and increased exposure to risks. The strong rally it has experienced suggests that its current valuation may not offer the most attractive entry point for new investments. Furthermore, the fund's performance is intrinsically linked to the health and growth of the technology and industrial sectors, making it susceptible to volatility in these areas.

Considering the substantial gains already realized and the inherent risks associated with a highly concentrated portfolio, a cautious stance is advisable. While EMEQ holds promise due to its focus on high-growth sectors within emerging markets, a more favorable risk-reward balance would likely emerge with a market correction or sustained exceptional earnings growth from its core holdings. Therefore, maintaining a 'HOLD' position seems prudent until such conditions materialize, offering a better opportunity for long-term investors.

More Articles
Finance
East West Bancorp: High Returns, Hidden Risks
East West Bancorp (EWBC) exhibits strong financial performance with impressive returns and efficiency, driven by its unique U.S.-Asia market strategy. However, its significant exposure to non-deposit funded institution (NDFI) lending introduces substantial, yet undisclosed, risks. Despite attractive valuations (P/TBV of 2.11, P/E of 12.28), the opacity surrounding these risks warrants a cautious 'Hold' rating.
By Robert KiyosakiJul 13, 2026
Finance
Cohen & Steers: Diversification From Mag 7
Cohen & Steers, Inc. (CNS) is currently rated as a BUY, supported by substantial fund inflows and an acceleration in REIT performance. The company's assets under management (AUM) reached $93 billion in Q1 2026, with an impressive track record of outperforming benchmarks over various periods. With REITs constituting nearly half of its AUM, CNS is well-positioned to capitalize on sector rotation and improving property fundamentals, offering a compelling investment opportunity.
By David RubensteinJul 13, 2026
Finance
Top Personal Loan Options for Pool Installation
Considering a new swimming pool for your home? This comprehensive guide explores the best personal loan options available to finance this significant investment. We delve into various lenders, highlighting their rates, terms, and specific advantages, from rapid funding to accommodating lower credit scores. Discover how to secure the ideal loan for your dream pool project.
By David RubensteinJul 13, 2026
Finance
Baird International and Global Growth Funds: Q2 2026 Performance Review
This report analyzes the performance of Baird's International and Global Growth Funds in Q2 2026. The International Growth Fund returned +10.39%, underperforming the MSCI ACWI ex-U.S. Index® ND's +14.49%. Key detractors included Alibaba and Lululemon, while Recruit and ASML contributed positively. The Global Growth Fund returned +12.18%, lagging behind the MSCI ACWI Index® ND's +14.93%, with Regeneron and TJX as major detractors, and Micron and ASML as top contributors.
By Mariana MazzucatoJul 13, 2026
Finance
HCA Healthcare: A Dominant Force in the U.S. Hospital Market
HCA Healthcare, the largest for-profit hospital operator in the U.S., stands out for its strong local market presence, efficient operations, strategic capital allocation, and consistent demand for its services. The company's focus on expanding outpatient care and its resilient financial performance, even during economic downturns, underscore its robust business model and long-term growth potential. With a commitment to internal development and shareholder returns, HCA Healthcare offers an attractive investment opportunity.
By Mariana MazzucatoJul 13, 2026